epi-net.eu

What It Is

EPI-Net (Epidemiology Network) is a European epidemiology research network whose core mission is to use data to combat antimicrobial resistance (AMR). Based on the crawled content, it is not a conventional marketing or SEO tool: it does not provide keyword research, search ranking monitoring, backlink analysis, or ad campaign optimization. Instead, it is a professional data and research platform for public health, clinical research, and policymaking.

Core Features and Data

EPI-Net’s core offerings include AMR and healthcare-associated infection surveillance databases, the Emerging Resistance Index (ERI), and clinical trial site selection services. Its surveillance databases cover AMR and healthcare-associated infection information in humans and animals, including prevalence, incidence, outbreaks, and emerging resistance. The page shows the most recent update as April 30, 2026. ERI measures the speed at which resistance to new antibiotics emerges by combining AMR trends, surveillance, drug usage, and outbreak data. The site selection service uses the Central Data Repository to integrate information such as resistance rates, trends, infections, outbreaks, and health system capacity, providing reports for AMR clinical trial planning.

Pricing and Support

The main content does not disclose any subscription pricing, commercial licensing terms, free trials, payment methods, or service levels. The platform offers “View data” and collaboration contact entry points. The PrIMAVeRa project also plans to build an open-source, web-based platform that uses mathematical models and epidemiological repositories to assess the impact of vaccines and monoclonal antibodies on resistant infections.

Pros and Cons

Its strengths are a clear research focus, backing from European initiatives such as IMI, Horizon 2020, and ECRAID, and data dimensions that are highly relevant to AMR use cases. It can support evidence-based policymaking, antimicrobial stewardship, and clinical trial decision-making. Its weaknesses are that the information is presented more like an academic project, with limited disclosure on database scale, APIs, access permissions, pricing, and technical support. It has almost no direct practical value for marketing or SEO teams.

Who It’s For and Access from China

It is better suited to public health institutions, university research teams, AMR R&D departments at pharmaceutical companies, clinical trial operations teams, and policy researchers. The main content does not mention access conditions from China, so this would need to be tested directly; payment methods are also not disclosed. If you are looking for an SEO alternative, consider Ahrefs, Semrush, Similarweb, Google Search Console, and similar tools. If your focus is AMR data, WHO GLASS and relevant ECDC surveillance resources may also be useful references.